1Q22 Investor Update
FINANCIAL HIGHLIGHTS
(in US$ thousands)
P&L / Cash Flow
Revenue
Adj. EBITDA
Interest Expense
Capital Expenditure
Balance Sheet
Cash
PP&E
Total Assets
Total Liabilities
Shareholder's Equity
FY 2021A
460,080
57,852
30,014
117,506
82,198
339,692
1,376,512
825,689
550,823
Q2 2021A
109,744
16,422
5,622
25,029
148,750
213,138
1,365,395
763,486
601,909
Q3 2021A
132,322
24,771
8,057
40,062
116,931
258,885
1,372,490
810,784
561,706
Q4 2021A
139,276
20,592
11,314
45,183
82,198
339,692
1,376,512
825,689
550,823
Q1 2022
123,087
16,832
11,244
29,511
168,424
355,968
1,482,443
952,743
529,700
Note: Results are reported in US GAAP; Q2 2021 Revenue and Adjusted EBITDA (Non-GAAP) are presented as Combined metrics, including the Ohio assets prior to close of the CannAscend transaction on
July 1, 2021
2022 Guidance
$625M - $675M
$120M - $135M
16
Columbia Care™View entire presentation